Polaris Industries, Inc. (NYSE:PII) delivered beat and raise results, influencing Wells Fargo to believe that the company has a number of 2013 growth drivers. The firm keeps its Outperform rating on the stock.
Lululemon Athletica Inc. (NASDAQ:LULU): According to UBS, Athleta is not a threat to lululemon near-term considering its size, positioning, pricing, and small store overlap. The firm stated that pricing is not a competitive advantage for Athleta and that the company’s broader focus has raised markdown risk. The firm keeps its Buy rating and a $88 price target on the stock.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>
EMC Corporation (NYSE:EMC) continues to be a top pick and best-in-breed name at Brean Capital ahead of earnings, and the firm thinks that the company continues to gain market share compared to NetApp (NASDAQ:NTAP) and Hewlett-Packard (NYSE:HPQ). The firm keeps a Buy rating and a $32 price target on the stock.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): According to Baird, new survey data indicates a surprising level of Eylea use already and significant projected near term growth, causing the firm to be confident that the drug has the ability to beat/raise through the next several quarters. Shares have an Outperform rating and a $175 price target.
Don’t Miss: Here’s Why Pharma Stocks are in Play.